National Institute for Cancer Research and Treatment’s Post

Have you received the latest updates from the Narrative? Stay connected with your peers by subscribing to the Narrative today. Explore the newest advancements in utilizing cancer data. Together, we can drive meaningful change against cancer. Sign up now at https://buff.ly/47Bhg51! #NAACCR #NAACCRnarrative #cancerdata

Carcinoid cancer, a type of neuroendocrine tumor primarily found in the gastrointestinal system, impacts thousands of lives each year. In the U.S., an estimated 8,000 cases of GI carcinoid tumors are diagnosed annually. This cancer type is 61% more common in women, reflecting a gender disparity that continues to intrigue researchers. This statistic highlights both the ongoing struggle and the importance of early detection and specialized treatment. By spreading awareness, we can contribute to better support and resources for those affected by carcinoid cancer! #CarcinoidCancer #CancerAwareness  #CancerPrevention 

Dr. Nat Pernick's personal project launched this spring on Curing Cancer Network and seeks to identify precursors for malignancies to better understand and treat cancer and reduce cancer deaths. Project Introduction: https://buff.ly/3LyfxEk Follow Curing Cancer Network on LinkedIn and X for the latest on the project! #CancerResearch #CancerPrevention #CuringCancerNetwork #PathologyOutlines

It’s Time to Accelerate Cancer Screening! 🌟 First-hand experiences are essential for understanding the state of #CancerScreening policies across Europe. Help us collect and identify best practices and lessons learned from across countries and across cancer types. 🔍 If you are intrested and involved in cancer screening, please take our survey 👉 https://buff.ly/48UOYT3

The Cologuard® test has been available to screen adults 45 years and older who are at average risk for colorectal cancer. For 10 years, it prioritized both convenience and efficacy for patients, transforming the CRC landscape. Looking forward to seeing the continuous impacts you’ll make on colon cancer screening into the future. #10YearsofCologuard Exact Sciences Read about Cologuard's Decade of Impact here: https://lnkd.in/gTB2xsR5

Read the second post in our Innovation Engine series, highlighting the importance of inclusive cancer research and access to effective treatments and how it advances the priorities of the #NationalCancerPlan.    Roswell Park’s Dr. Song Yao discusses immune checkpoint therapy and how we can work to make it even more effective in cancer patients of African ancestry. Learn more here: https://lnkd.in/gMKTzpd4 #InnovationEngine #CancerMoonshot

"With the work Garvan is doing, cancer doesn’t have to mean what it did decades ago. By supporting medical research, you extend lives. It’s wonderful,” - Nicole, Garvan Research Participant. Garvan’s latest research targeting dormant cancer cells to stop relapse could be life-saving for people like Nicole. Your support can help pioneer a future where all cancers can be effectively treated, controlled and prevented. Find out more: https://ow.ly/3gla50SeZtm

#DYK Lung cancer is the second most common cancer in both men and women in the US? This #LungCancerAwarenessMonth, explore the @AllofUsResearch Research Projects Directory to learn how researchers are working to understand the risk, treatment, and prevention of lung cancer: https://lnkd.in/eWcwxG9S #Reasons4Research #JoinAllofUs #AllofUsARC

During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents for Head and Neck Cancer - Cesar Perez M.D. Florida Cancer Specialists & Research Institute #ASCO2024 #EducationalSession #Cancer #CancerSpecialists #Research #SquamousCellCarcinoma #OncoDaily #Oncology #Immunotherapy

This #WorldCancerResearchDay, explore the incredible advancements in cancer screening, diagnosis, and treatment. The #RewritingCancer series, featuring Polymedco, highlights exciting progress in non-invasive options, patient involvement in CRC screening. Discover more in Rewriting Cancer, streaming now.